462 related articles for article (PubMed ID: 10234806)
1. Multiple differentiation pathways of rat mammary stromal cells in vitro: acquisition of a fibroblast, adipocyte or endothelial phenotype is dependent on hormonal and extracellular matrix stimulation.
Zangani D; Darcy KM; Masso-Welch PA; Bellamy ES; Desole MS; Ip MM
Differentiation; 1999 Jan; 64(2):91-101. PubMed ID: 10234806
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
3. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of vascular endothelial growth factor expression in epithelial and stromal cells during mouse mammary gland development.
Hovey RC; Goldhar AS; Baffi J; Vonderhaar BK
Mol Endocrinol; 2001 May; 15(5):819-31. PubMed ID: 11328861
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated wild-type p53 overexpression inhibits endothelial cell differentiation in vitro and angiogenesis in vivo.
Riccioni T; Cirielli C; Wang X; Passaniti A; Capogrossi MC
Gene Ther; 1998 Jun; 5(6):747-54. PubMed ID: 9747454
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenesis by the cancer chemopreventive agent conjugated linoleic acid.
Masso-Welch PA; Zangani D; Ip C; Vaughan MM; Shoemaker S; Ramirez RA; Ip MM
Cancer Res; 2002 Aug; 62(15):4383-9. PubMed ID: 12154044
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis by fibroblast growth factor 4 is mediated through an autocrine up-regulation of vascular endothelial growth factor expression.
Deroanne CF; Hajitou A; Calberg-Bacq CM; Nusgens BV; Lapière CM
Cancer Res; 1997 Dec; 57(24):5590-7. PubMed ID: 9407972
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels.
Goto F; Goto K; Weindel K; Folkman J
Lab Invest; 1993 Nov; 69(5):508-17. PubMed ID: 8246443
[TBL] [Abstract][Full Text] [Related]
9. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
10. The 230 kDa mature form of KDR/Flk-1 (VEGF receptor-2) activates the PLC-gamma pathway and partially induces mitotic signals in NIH3T3 fibroblasts.
Takahashi T; Shibuya M
Oncogene; 1997 May; 14(17):2079-89. PubMed ID: 9160888
[TBL] [Abstract][Full Text] [Related]
11. The coronary endothelium: a target for vascular endothelial growth factor. Human coronary artery endothelial cells express functional receptors for vascular endothelial growth factor in vitro and in vivo.
Kranz A; Mayr U; Frank H; Waltenberger J
Lab Invest; 1999 Aug; 79(8):985-91. PubMed ID: 10462036
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
13. A simple immunomagnetic protocol for the selective isolation and long-term culture of human dermal microvascular endothelial cells.
Richard L; Velasco P; Detmar M
Exp Cell Res; 1998 Apr; 240(1):1-6. PubMed ID: 9570915
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas.
Berard M; Sordello S; Ortega N; Carrier JL; Peyri N; Wassef M; Bertrand N; Enjolras O; Drouet L; Plouet J
Am J Pathol; 1997 Apr; 150(4):1315-26. PubMed ID: 9094988
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
16. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
[TBL] [Abstract][Full Text] [Related]
17. Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells.
Wang D; Lehman RE; Donner DB; Matli MR; Warren RS; Welton ML
Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G1088-96. PubMed ID: 12016135
[TBL] [Abstract][Full Text] [Related]
18. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
[TBL] [Abstract][Full Text] [Related]
19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
20. The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.
Mendel DB; Schreck RE; West DC; Li G; Strawn LM; Tanciongco SS; Vasile S; Shawver LK; Cherrington JM
Clin Cancer Res; 2000 Dec; 6(12):4848-58. PubMed ID: 11156244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
